Point72 Asset Management
FULC icon

Point72 Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Point72 Asset Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
651,427
-1,423,428
-69% -$8.66M ﹤0.01% 2269
2026
Q1 		$15.9M Sell
2,074,855
-323,377
-13% -$3M 0.02% 938
2025
Q4 		$27.1M Buy
+2,398,232
New +$24.4M 0.03% 710
2025
Q3 		– Sell
-498,219
Closed -$3.43M – 2444
2025
Q2 		$3.43M Buy
+498,219
New +$2.66M 0.01% 1105
2024
Q2 		– Sell
-223,400
Closed -$2.11M – 2058
2024
Q1 		$2.11M Buy
+223,400
New +$1.99M 0.01% 1251
2023
Q3 		– Sell
-1,899,968
Closed -$6.27M – 2603
2023
Q2 		$6.27M Sell
1,899,968
-743,704
-28% -$2.19M 0.02% 743
2023
Q1 		$7.53M Buy
+2,643,672
New +$23.7M 0.02% 636
2022
Q4 		– Sell
-1,494,003
Closed -$12.1M – 1610
2022
Q3 		$12.1M Sell
1,494,003
-494,797
-25% -$3.54M 0.05% 454
2022
Q2 		$9.74M Buy
1,988,800
+1,663,800
+512% +$16.3M 0.04% 512
2022
Q1 		$7.69M Sell
325,000
-180,655
-36% -$2.56M 0.03% 582
2021
Q4 		$8.95M Buy
505,655
+365,655
+261% +$7.24M 0.04% 540
2021
Q3 		$3.95M Sell
140,000
-412,885
-75% -$7.82M 0.02% 703
2021
Q2 		$5.79M Sell
552,885
-22,361
-4% -$226K 0.03% 583
2021
Q1 		$6.78M Sell
575,246
-762,877
-57% -$9.43M 0.03% 518
2020
Q4 		$15.7M Sell
1,338,123
-171,877
-11% -$1.94M 0.08% 337
2020
Q3 		$12M Buy
1,510,000
+1,249,303
+479% +$15M 0.06% 375
2020
Q2 		$4.77M Buy
+260,697
New +$4.1M 0.03% 490

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management's FULC Position: Q2 2026 in Review

Point72 Asset Management reduced its Fulcrum Therapeutics (FULC) stake by 69% in Q2 2026, selling an estimated $8.66M and leaving 651,427 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Point72 Asset Management first reported a position in FULC in Q2 2020 and has held it in 17 quarters since. The position peaked at $27.1M in Q4 2025. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Point72 Asset Management held 651,427 shares of Fulcrum Therapeutics worth $2.38M as of Q2 2026.
  • Point72 Asset Management sold 1,423,428 Fulcrum Therapeutics shares in Q2 2026, an estimated $8.66M.
  • Fulcrum Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2269 holding.
  • Point72 Asset Management first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Point72 Asset Management's Fulcrum Therapeutics position peaked at $27.1M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.